Skip to content

Blog

September 27, 2023

Embracing Clarity: Celebrating the 2nd Annual World Dense Breast Day

At iCAD, we are recognizing the 2nd annual World Dense Breast Day today, a day that holds significant importance, not only for the women who may have dense breasts but for all of us dedicated to advancing breast health awareness and early cancer detection. As we gather to mark this...

August 14, 2023

Joining Forces with Google to Revolutionize Breast Cancer Screening Worldwide

by Dana Brown, President and CEO of iCAD, Inc. We’ve joined forces with Google Health once again to address two of the most pressing challenges in healthcare: the global radiologist shortage and significant disparities in healthcare. Per our 20-year worldwide agreement, Google’s AI technology will seamlessly integrate into our ProFound...

May 13, 2023

What is Breast Density?

A woman’s breast is primarily made up of fat and fibroglandular breast tissue, which is the network of milk glands and ducts designed to produce and transport milk to the nipple for breast feeding. Fibrous tissue, also known as connective tissue, supports the breast and holds everything in place. When...

April 13, 2023

What is CAD?

Computer-Aided Detection (CAD) is a sophisticated FDA-approved technology that helps radiologists identify characteristics that may be associated with various forms of cancer. By using iCAD patented algorithms to mark suspicious areas, CAD serves as a “second pair of eyes” and acts very much like a “spell checker” to identify characteristics...

September 20, 2022

Why RCI Became the First in the State to Adopt ProFound AI as its Breast AI Solution for Mammography

Iowa’s largest radiology group, Radiology Consultants of Iowa (RCI), offers a wide range of imaging services for patients, including breast cancer screening. In addition to the mammograms done at their imaging center, which is accredited by the American College of Radiology (ACR) as a Breast Imaging Center of Excellence, RCI...

May 16, 2022

New Research Finds iCAD’s ProFound AI Risk for Digital Breast Tomosynthesis is 2.4x More Accurate than Traditional Lifetime Risk Models

Using U.S. guidelines, ProFound AI Risk found 14% of women studied who had a negative screen hadalmost 20 times higher risk of developing breast cancer in the next year than the general risk population iCAD recently announced that promising clinical research supporting ProFound AI® Risk for Digital Breast Tomosynthesis (DBT)...

April 4, 2022

Why ProFound AI Prevailed as the Premier AI Solution in a Competitive Trial at Wake Radiology

With 14 imaging locations in the Raleigh-Durham metropolitan area, also known as “the Triangle,” Wake Radiology offers a wide array of imaging exams in the outpatient setting, including both screening and diagnostic mammography. Renowned for state-of-the-art care, in August 2013 Wake Radiology began to upgrade to 3D mammography, or DBT,...

March 15, 2022

Why Kettering Health Traded out Previous AI Software for ProFound AI® Enterprise-Wide

The Story of Kettering Health A leading faith based, not-for-profit hospital system in southwest Ohio, Kettering Health has been providing quality patient care and cancer screening at its world-class cancer centers for 48 years. The team at Kettering takes great pride in ensuring that its facilities are equipped with the...

September 16, 2021

ImageCare Centers Unveils PINK Better Mammo Service, Featuring Profound AI®, the World’s First FDA Cleared Artificial Intelligence Solution for 3D Mammography

ImageCare Centers recently announced it will adopt ProFound AI® for Digital Breast Tomosynthesis (DBT) throughout all of ImageCare’s mammography centers this October as part of its “PINK Better Mammo” service. ProFound AI® was the first artificial intelligence (AI) software for DBT, or 3D mammography, to be FDA cleared; the software...

June 28, 2021

Rabin Medical Center Evaluates iCAD’s ProFound AI to Improve Accuracy and Efficiency

Rabin Medical Center (RMC), one of the most prominent and largest medical facilities in Israel, recently initiated a clinical evaluation involving ProFound AI® for Digital Breast Tomosynthesis (DBT) at the Radiology Department at the Clalit Rabin Medical Center. Owned and operated by Clalit Health Services, RMC is Israel’s largest health...